APR 13, 2020 10:48 PM PDT

Experimental Drug Prevents Cancer Relapse

WRITTEN BY: Nouran Amin

One of the main challenges of cancer treatments is preventing the cancer from returning again—in essence stopping relapse. As part of a study, researchers found that a well-tolerated drug prevents relapse in mouse models.

Findings were published in Nature Communications and shows that the drug, Quisinostat, can block stop tumor re-growth and stop expansion of surviving human cancer cells in culture. Quisinostat works by elevating the protein levels of histone H1.0 within the tumor cells which prevents these cells from replicating.

"This drug works by disabling the cells that fuel long-term cancer growth and drive disease relapse. These early findings even suggest it may be more effective than commonly used drugs that inhibit tumor growth,” says Cristina Morales Torres, lead author and Principal Laboratory Research Scientist in the Cancer Epigenetics Laboratory at the Francis Crick Institute. "Further research is still needed to confirm whether this drug could prevent cancer coming back in people or if it could be used to control someone's disease long term."

When researchers examined the drug in mice, they found that it halted growth significantly. They tested it further on cancer cells taken from the breast, lung, and pancreases—results suggested that Quisinostat trapped the cancer cells in a non-dividing state.

Learn more about cancer biology:

Paola Scaffidi, co-author and Group Leader of the Cancer Epigenetics Laboratory at the Crick and Professorial Research Associate at the UCL Cancer Institute, says: "Just like stem cells that continuously produce progeny to keep our normal tissues healthy, cancer cells grow, divide and use energy. That's why finding a potential drug that halts tumour growth without hurting normal cells has been a challenge. Excitingly, with Quisinostat, we've seen no harm to healthy stem cells in our initial studies."

Source: Science Daily

 

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
DEC 27, 2020
Genetics & Genomics
Delivering DNA- & RNA-Based Therapies in a New Way
DEC 27, 2020
Delivering DNA- & RNA-Based Therapies in a New Way
Gene therapy holds tremendous promise for its potential to cure genetic diseases. We've also recently seen how critical ...
DEC 30, 2020
Cannabis Sciences
Cannabis Reduces Stress and Anxiety in Over 95% of Cases
DEC 30, 2020
Cannabis Reduces Stress and Anxiety in Over 95% of Cases
Whether cannabis will induce feelings of relaxation or anxiety often feels like a coin toss. Now, however, researchers f ...
FEB 20, 2021
Drug Discovery & Development
Deep Brain Stimulation Offsets Epileptic Seizures
FEB 20, 2021
Deep Brain Stimulation Offsets Epileptic Seizures
Researchers from the University of Freiburg in Germany have found that deep brain stimulation (DBS) in the brain’s ...
FEB 22, 2021
Drug Discovery & Development
Screening Macrocyclic Peptides
FEB 22, 2021
Screening Macrocyclic Peptides
Macrocyclic peptides are promising for pharmaceuticals for cancer—however, screening for them is challenging. Find ...
MAR 12, 2021
Drug Discovery & Development
Drug Starves Melanoma Tumors
MAR 12, 2021
Drug Starves Melanoma Tumors
Scientists at Sanford Burnham Prebys Medical Discovery Institute have identified a drug candidate that blocks the uptake ...
APR 13, 2021
Immunology
The "Unexpected" Reason Why COVID Antivirals Don't Work
APR 13, 2021
The "Unexpected" Reason Why COVID Antivirals Don't Work
Purdue University researchers have made a breakthrough finding that could explain why the disease is so hard to manage t ...
Loading Comments...